NONOF Novo Nordisk A/S

USD 126.50 -0.95 -0.74539
Icon

Novo Nordisk A/S (NONOF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 126.50

-0.95 (-0.75)%

USD 599.92B

4.34K

N/A

N/A

Icon

NONOF

Novo Nordisk A/S (USD)
COMMON STOCK | OTC
USD 126.50
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 599.92B

N/A

USD 126.50

Novo Nordisk A/S (NONOF) Stock Forecast

N/A

Based on the Novo Nordisk A/S stock forecast from 0 analysts, the average analyst target price for Novo Nordisk A/S is not available over the next 12 months. Novo Nordisk A/S’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Novo Nordisk A/S is Slightly Bullish , which is based on 11 positive signals and 6 negative signals. At the last closing, Novo Nordisk A/S’s stock price was USD 126.50. Novo Nordisk A/S’s stock price has changed by -2.32% over the past week, +4.33% over the past month and +63.67% over the last year.

No recent analyst target price found for Novo Nordisk A/S
No recent average analyst rating found for Novo Nordisk A/S

Company Overview Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segmen...Read More

https://www.novonordisk.com

Novo Alle 1, Bagsvaerd, Denmark, 2880

63,370

December

USD

USA

Adjusted Closing Price for Novo Nordisk A/S (NONOF)

Loading...

Unadjusted Closing Price for Novo Nordisk A/S (NONOF)

Loading...

Share Trading Volume for Novo Nordisk A/S Shares

Loading...

Compare Performance of Novo Nordisk A/S Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NONOF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Novo Nordisk A/S (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSLLY
CSL Ltd +0.41 (+0.44%) USD91.31B 37.10 23.35

ETFs Containing NONOF

Symbol Name NONOF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Novo Nordisk A/S (NONOF) Stock

Stock Target Advisor's fundamental analysis for Novo Nordisk A/S's stock is Slightly Bullish .

NONOF stock's dividend yield is 1.41%. Our analysis grades NONOF stock's dividend yield at F. This means that NONOF stock's dividend yield is above 53% of the stocks in the Biotechnology sector in the OTC exchange. Based on this NONOF may be a average dividend stock for its sector.

Unfortunately we do not have enough data on NONOF's stock to indicate what its average analyst target is.

NONOF stock's Price/Earning ratio is 48.04. Our analysis grades NONOF stock's Price / Earning ratio at F. This means that NONOF stock's Price/Earning ratio is above 76% of the stocks in the Biotechnology sector in the OTC exchange. Based on this NONOF may be a overvalued for its sector.

The last closing price of NONOF's stock was USD 126.50.

The most recent market capitalization for NONOF is USD 599.92B.

Unfortunately we do not have enough analyst data on NONOF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Novo Nordisk A/S's stock.

As per our most recent records Novo Nordisk A/S has 63,370 Employees.

Novo Nordisk A/S's registered address is Novo Alle 1, Bagsvaerd, Denmark, 2880. You can get more information about it from Novo Nordisk A/S's website at https://www.novonordisk.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...